By: James Pitt  Jul. 26, 2018
Venous thromboembolism (VTE) is a common and often preventable condition in which a blood clot forms, breaks loose, and lodges elsewhere. A June 26, 2018 study in Journal of the American Heart Association by Secemsky et. al analyzed CMS data on all-cause readmissions after VTE discharges from 2010-2014. From 2010-2014, 17.5% of patients discharged alive after acute VTE were readmitted to the hospital within 30 days. Secemsky et. al attribute a total $10 billion in annual US healthcare costs to VTE, and report that these 30-day readmissions account for “a nationally weighted annual cost totaling $1.44 billion.”
As a case study, Dexur analysts examined the converse of Secemsky's data: VTE readmissions after all-cause discharges. The sample consists of CMS inpatient discharge data on 2013-2016 VTE readmissions at seven Pittsburgh, PA hospitals.
The highest rate of VTE readmissions after all-cause discharges was 1.31% at Allegheny General Hospital, and the lowest 0.57% at UPMC St. Margaret.
Surgery is a recognized risk factor for preventable VTEs. At five Pittsburgh hospitals, VTE readmissions were slightly more common after surgical discharges than after non-surgical discharges. At UPMC Mercy Hospital, surgical discharges were nearly twice as likely as non-surgical discharges to be readmitted with VTE within 30 days (1.45% of surgical discharges vs 0.75% of non-surgical disc). Magee Women's Hospital reversed the general trend, with half as many VTE readmissions in surgical patients as in non-surgical patients (0.75% of surgical vs 1.57% of non-surgical discharges). This may indicate opportunities to improve VTE prevention.
From 2013-2016, for all CMS inpatient discharges and grouped by surgical and non-surgical discharges, for the following hospitals: